Showing 60,441 - 60,460 results of 113,932 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.37s Refine Results
  1. 60441

    Image_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  2. 60442

    Table_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOCX by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  3. 60443

    Table_3_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOC by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  4. 60444

    Table_4_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOC by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  5. 60445

    Image_1_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  6. 60446

    Image_3_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  7. 60447

    Image_4_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.TIF by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  8. 60448

    The UpSetR plot showing the frequency of the use of a particular method and their intersections in studies on the occurrence of <i>Mycoplasma gallisepticum</i> in wild birds from 1... by Anna Sawicka (180114)

    Published 2020
    “…The dot pattern shows the intersections between methods used and the vertical bars at the top of the plot show the number of the corresponding intersection, ranked by a decreasing number of studies.</p>…”
  9. 60449

    The duty cycle of the feet changes with walking speed. by John A. Bender (335471)

    Published 2013
    “…Each diamond represents the mean and s.e.m. of both stride period and duty cycle for a single bout of walking. (C) Same data as panel A, but with stance phase determined by the TiTa points' <i>z</i>-values, as for the gray boxes in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0013617#pone-0013617-g008" target="_blank">Fig. 8</a>. …”
  10. 60450

    Using centrosome dynamics to study cytosolic loading of molecular motors. by Rafael A. Longoria (428918)

    Published 2013
    “…<p>(A)A schematic sketch of a convex-up force-velocity (F–v) relation for a molecular motor shows that the velocity of the motor decreases only slightly up to an opposing load of about one half its stall force then decreases precipitously. …”
  11. 60451
  12. 60452

    Bacterial taxa abundance differ in the inside compared to the outside microenvironments of stool. by Monika A. Gorzelak (781453)

    Published 2015
    “…<p>A single stool was subsampled five times from the inside environment and five times from the outer environment, DNA was extracted and used to compare bacterial taxa via qPCR. …”
  13. 60453

    Image_1_Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospecti... by Agata Popielarz-Grygalewicz (15424142)

    Published 2023
    “…Biochemical control on SRL was achieved in 25.8% of patients after 6 months and complete surgical remission was achieved in 41.7% of patients. TSS resulted in decrease in median (IQR) IGF-1 compared to IGF-1 levels on SRL treatment: from 1.5(1.2-2.5) to 1.3(1.0-1.6) xULN (p=0.003). …”
  14. 60454

    Image_3_Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospecti... by Agata Popielarz-Grygalewicz (15424142)

    Published 2023
    “…Biochemical control on SRL was achieved in 25.8% of patients after 6 months and complete surgical remission was achieved in 41.7% of patients. TSS resulted in decrease in median (IQR) IGF-1 compared to IGF-1 levels on SRL treatment: from 1.5(1.2-2.5) to 1.3(1.0-1.6) xULN (p=0.003). …”
  15. 60455

    Image_4_Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospecti... by Agata Popielarz-Grygalewicz (15424142)

    Published 2023
    “…Biochemical control on SRL was achieved in 25.8% of patients after 6 months and complete surgical remission was achieved in 41.7% of patients. TSS resulted in decrease in median (IQR) IGF-1 compared to IGF-1 levels on SRL treatment: from 1.5(1.2-2.5) to 1.3(1.0-1.6) xULN (p=0.003). …”
  16. 60456

    Image_2_Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospecti... by Agata Popielarz-Grygalewicz (15424142)

    Published 2023
    “…Biochemical control on SRL was achieved in 25.8% of patients after 6 months and complete surgical remission was achieved in 41.7% of patients. TSS resulted in decrease in median (IQR) IGF-1 compared to IGF-1 levels on SRL treatment: from 1.5(1.2-2.5) to 1.3(1.0-1.6) xULN (p=0.003). …”
  17. 60457
  18. 60458
  19. 60459

    Modulation of synaptic transmission by capsaicin at the first sensory synapse in spinal cord. by Joseph A. Jeffry (259692)

    Published 2009
    “…Superimposed traces (10) of evoked synaptic responses recorded at three different time points from the same neurons. In the presence of capsaicin eEPSCs either failed or exhibited a reduction in amplitude. …”
  20. 60460

    Temporal alignment schemas. by Jason A. Shaw (742604)

    Published 2015
    “…<p>Schematic representation of three intervals, left edge to anchor (LE-A), center to anchor (CC-A) and right edge to anchor (RE-A), delineated by points in an initial single consonant, /r/ (top row), or consonant cluster, /kr/ (bottom row), and a common anchor (A). …”